2,4-Diaminoquinazolines as antithrombotic agents

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602564Q, 2602475DP, A61K 31505

Patent

active

039564959

ABSTRACT:
2,4-diaminoquinazolines are employed as antithrombotic agents and have the following general formula: ##SPC1##
Wherein R.sub.1 and R.sub.2 are monovalent groups independently selected from the group consisting of ##EQU1## wherein R.sub.4 and R.sub.5 independently are selected from the group consisting of hydrogen, alkyl, and cycloalkyl, with the proviso that both R.sub.4 and R.sub.5 cannot be cycloalkyl, ##EQU2## wherein R.sub.6, R.sub.7, and R.sub.8 independently are selected from the group consisting of hydrogen and alkyl, and A is a divalent organic group having from two to about six carbon atoms such that the two nitrogen atoms are separated by at least two carbon atoms, and

REFERENCES:
patent: 2794018 (1957-05-01), Spinks et al.
patent: 2945859 (1960-07-01), Hitchings et al.
patent: 3511836 (1970-05-01), Hess

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,4-Diaminoquinazolines as antithrombotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,4-Diaminoquinazolines as antithrombotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-Diaminoquinazolines as antithrombotic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1304385

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.